Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2005 1
2006 1
2007 3
2009 2
2010 1
2011 1
2013 2
2014 3
2015 2
2016 1
2017 1
2018 2
2020 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam.
Bwire GM, Aiko BG, Mosha IH, Kilapilo MS, Mangara A, Kazonda P, Swai JP, Swalehe O, Jordan MR, Vercauteren J, Sando D, Temba D, Shao A, Mauka W, Decouttere C, Vandaele N, Sangeda RZ, Killewo J, Vandamme AM. Bwire GM, et al. Sci Rep. 2023 Nov 22;13(1):20493. doi: 10.1038/s41598-023-47795-1. Sci Rep. 2023. PMID: 37993493 Free PMC article.
Patients with unsuppresed viral loads (local criteria viral load (VL) 1000 copies/mL) were tested for HIVDR mutations using the WHO adapted protocol for plasma samples. ...In samples successfully genotyped in the three genetic regions, 68.18% (16/22) had a genotypic …
Patients with unsuppresed viral loads (local criteria viral load (VL) 1000 copies/mL) were tested for HIVDR mutations using th …
Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa.
Nkurunziza J, Karstaedt AS, Louw R, Padanilam X. Nkurunziza J, et al. Int J Tuberc Lung Dis. 2018 Dec 1;22(12):1469-1474. doi: 10.5588/ijtld.18.0205. Int J Tuberc Lung Dis. 2018. PMID: 30606319
METHODS: A retrospective medical record review was conducted of patients with pulmonary pre-XDR-TB and XDR-TB managed from 2008 to 2010 at Sizwe Tropical Disease Hospital, Johannesburg, South Africa. Standardised MDR-TB treatment was instituted and was subsequently individ …
METHODS: A retrospective medical record review was conducted of patients with pulmonary pre-XDR-TB and XDR-TB managed from 2008 to 2010 at S …
The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment.
Berges BK, Rowan MR. Berges BK, et al. Retrovirology. 2011 Aug 11;8:65. doi: 10.1186/1742-4690-8-65. Retrovirology. 2011. PMID: 21835012 Free PMC article. Review.
New models have been successfully infected by a variety of strains of Human Immunodeficiency Virus Type 1 (HIV-1), accompanied by virus replication in lymphoid and non-lymphoid organs, including the gut-associated lymphoid tissue, the male and female reproduc …
New models have been successfully infected by a variety of strains of Human Immunodeficiency Virus Type 1 (HIV-1), accompanied …
Interventions for the treatment of decreased bone mineral density associated with HIV infection.
Lin D, Rieder MJ. Lin D, et al. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005645. doi: 10.1002/14651858.CD005645.pub2. Cochrane Database Syst Rev. 2007. PMID: 17443607 Review.
BACKGROUND: Decreased bone mineral density (BMD) occurs more commonly in patients with HIV than in the general population, making this group more susceptible to fragility fractures. However, bone loss is under-treated in patients with HIV. ...SELECTION CRITERIA: Randomised …
BACKGROUND: Decreased bone mineral density (BMD) occurs more commonly in patients with HIV than in the general population, making this group …
Metabolic Profile of People Living with HIV in a Treatment Hub in Manila, Philippines: A Pre- and Post-Antiretroviral Analysis.
Francisco C, Gonzales E, Yu MG, Salvaña EM, Abad C, Reganit PF, Maningat P, Sison O, Alejandria M. Francisco C, et al. J ASEAN Fed Endocr Soc. 2022;37(1):53-61. doi: 10.15605/jafes.037.01.17. Epub 2022 Feb 18. J ASEAN Fed Endocr Soc. 2022. PMID: 35800599 Free PMC article. Review.
OBJECTIVES: People living with HIV (PLHIV) are susceptible to develop dyslipidemia and hyperglycemia. This study aims to determine the prevalence of these metabolic derangements among Filipino PLHIV. ...RESULTS: Among 635 PLHIV, 97.3% were males with mean age of 30 years a …
OBJECTIVES: People living with HIV (PLHIV) are susceptible to develop dyslipidemia and hyperglycemia. This study aims to determine th …
Shortened Tuberculosis Treatment for People with HIV in South Africa. A Model-based Evaluation and Cost-effectiveness Analysis.
Reddy KP, Horsburgh CR, Wood R, Fields NF, Girouard MP, Costantini S, Hou T, Freedberg KA, Walensky RP. Reddy KP, et al. Ann Am Thorac Soc. 2020 Feb;17(2):202-211. doi: 10.1513/AnnalsATS.201905-418OC. Ann Am Thorac Soc. 2020. PMID: 31689133 Free PMC article.
Novel shortened regimens may still have important clinical and economic benefits in populations with high loss to follow-up (LTFU) and in subgroups such as people with human immunodeficiency virus.Objectives: To identify scenarios in which a novel 4m regimen would b …
Novel shortened regimens may still have important clinical and economic benefits in populations with high loss to follow-up (LTFU) and in su …
Time to sputum culture conversion and treatment outcome among the first cohort of multidrug resistant tuberculosis patients in a high burden country.
Ige OM, Oladokun RE. Ige OM, et al. Indian J Tuberc. 2018 Oct;65(4):322-328. doi: 10.1016/j.ijtb.2018.07.006. Epub 2018 Aug 9. Indian J Tuberc. 2018. PMID: 30522620
RESULTS: A total of 115 patients were studied consisting of 76 (66.1%) males and 39 (33.9%) females with ages ranging between 15 and 65 years. Median time to sputum conversion was 2.06 months (95% confident interval [CI] = 1.82, 2.30). At the end of the first month, 43 (37 …
RESULTS: A total of 115 patients were studied consisting of 76 (66.1%) males and 39 (33.9%) females with ages ranging between 15 and 65 …
Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes.
Monge S, Diez M, Pulido F, Iribarren JA, Campins AA, Arazo P, Montero M, Miro JM, Moreno S, Del Amo J; Spanish AIDS Research Network Cohort (CoRIS). Monge S, et al. Int J Tuberc Lung Dis. 2014 Jun;18(6):700-8. doi: 10.5588/ijtld.13.0778. Int J Tuberc Lung Dis. 2014. PMID: 24903942
OBJECTIVE: To describe tuberculosis (TB) incidence, risk factors, clinical presentation, disease management and outcomes in human immunodeficiency virus (HIV) infected patients from the CoRIS cohort, Spain, 2004-2010. ...Overall, 87% were new cases and 13% we …
OBJECTIVE: To describe tuberculosis (TB) incidence, risk factors, clinical presentation, disease management and outcomes in human …
Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.
Aibana O, Bachmaha M, Krasiuk V, Rybak N, Flanigan TP, Petrenko V, Murray MB. Aibana O, et al. BMC Infect Dis. 2017 Feb 7;17(1):129. doi: 10.1186/s12879-017-2230-2. BMC Infect Dis. 2017. PMID: 28173763 Free PMC article.
We used logistic regression analyses to identify baseline patient characteristics associated with poor MDR-TB treatment outcomes. RESULTS: Among 360 patients, 65 (18.1%) achieved treatment cure or completion while 131 (36.4%) died, 115 (31.9%) defaulted, and 37 (10.3%) fai …
We used logistic regression analyses to identify baseline patient characteristics associated with poor MDR-TB treatment outcomes. RESULTS: A …
Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa.
Marais E, Mlambo CK, Lewis JJ, Rastogi N, Zozio T, Grobusch MP, Duse A, Victor T, Warren RW. Marais E, et al. Infection. 2014 Apr;42(2):405-13. doi: 10.1007/s15010-013-0572-2. Epub 2013 Dec 21. Infection. 2014. PMID: 24363208
METHODS: The study involved the assessment of factors associated with treatment outcomes using a retrospective review of patient records, drug-susceptibility data and spoligotyping of isolates. RESULTS: Treatment success (completion/cure) was recorded in 158 (48.8 %) patie …
METHODS: The study involved the assessment of factors associated with treatment outcomes using a retrospective review of patient records, dr …
21 results